Literature DB >> 9321947

Selective cyclooxygenase-2 inhibitors as potential therapeutic agents for inflammatory diseases.

C C Chan1, I W Rodger.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9321947     DOI: 10.1007/978-1-4899-1813-0_24

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


× No keyword cloud information.
  4 in total

Review 1.  Cyclo-oxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy.

Authors:  J A Mitchell; T D Warner
Journal:  Br J Pharmacol       Date:  1999-11       Impact factor: 8.739

2.  Macrophage responses to lipopolysaccharide are modulated by a feedback loop involving prostaglandin E2, dual specificity phosphatase 1 and tristetraprolin.

Authors:  Tina Tang; Thomas E Scambler; Tim Smallie; Helen E Cunliffe; Ewan A Ross; Dalya R Rosner; John D O'Neil; Andrew R Clark
Journal:  Sci Rep       Date:  2017-06-28       Impact factor: 4.379

Review 3.  Current perspectives in NSAID-induced gastropathy.

Authors:  Mau Sinha; Lovely Gautam; Prakash Kumar Shukla; Punit Kaur; Sujata Sharma; Tej P Singh
Journal:  Mediators Inflamm       Date:  2013-03-12       Impact factor: 4.711

4.  Dapsone modulates lipopolysaccharide-activated bone marrow cells by inducing cell death and down-regulating tumor necrosis factor-α production.

Authors:  Min-Ji Kwon; Hong-Gu Joo
Journal:  J Vet Sci       Date:  2018-11-30       Impact factor: 1.672

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.